ABSTRACT
The present study aimed at examining postnatal repairability of sodium valproate-induced skeletal alterations in rats. Sodium valproate (400 mg/kg) or the vehicle (distilled water) was orally administrated to pregnant Sprague-Dawley rats from gestation days 9 to 11. Fetuses and pups were obtained on gestation day 21 and postnatal day 11, respectively, and their skeletons were stained with Alizarin red S and Alcian blue and examined. Sodium valproate-induced costal and vertebral alterations in the fetuses included discontinued rib cartilage, fused rib, full or short supernumerary rib, bipart ossification of thoracic centrum, supernumerary lumbar vertebrae, and lumbarization. In pups, however, discontinued rib cartilage was not observed, and the incidence of a short supernumerary rib was significantly lower than that in the fetuses, suggesting that these alterations are postnatally repairable.
Subject(s)
Abnormalities, Drug-Induced/rehabilitation , Anticonvulsants/adverse effects , Bone Regeneration/physiology , Musculoskeletal Abnormalities/rehabilitation , Valproic Acid/adverse effects , Abnormalities, Drug-Induced/pathology , Administration, Oral , Alcian Blue , Animals , Animals, Newborn , Anthraquinones , Cartilage/drug effects , Cartilage/pathology , Female , Fetus , Gestational Age , Lumbar Vertebrae/drug effects , Lumbar Vertebrae/pathology , Maternal Exposure , Musculoskeletal Abnormalities/chemically induced , Musculoskeletal Abnormalities/pathology , Pregnancy , Rats , Rats, Sprague-Dawley , Ribs/drug effects , Ribs/pathology , Thoracic Vertebrae/drug effects , Thoracic Vertebrae/pathologyABSTRACT
This study sought to clarify the effects of reduced feeding on physiological parameters in dogs to enable appropriate evaluations of the safety and toxicity of test compounds. We measured alkaline phosphatase isozymes and the circulating blood volume, as well as clinical signs, body weight, hematology, blood chemistry, electrocardiography, organ weight, and histopathology, in male beagle dogs fed a diet consisting of 300 g/day or 150 g/day for 4 weeks. There were no abnormal clinical signs in any of the dogs. In the 150-g/day feeding group, a decreased alkaline phosphatase 3 suggesting effects on the bone and a decreased circulating blood volume associated with body weight loss were observed. Additionally, the following changes were also observed in the 150-g/day group: a decrease in body weight; hematologic changes including decreases in white blood cells, neutrophils, red blood cells, hemoglobin, hematocrit and reticulocytes; blood chemical changes including decreases in aspartate aminotransferase, lactate dehydrogenase and calcium and an increase in the creatinine at week 1 or thereafter; electrocardiographic changes including a decrease in the heart rate, a prolonged QRS duration and the occurrence of a second-degree atrioventricular block at week 3 or thereafter; and pathological changes including decreases in the weights of the liver and thymus, a decrease in hepatocyte rarefaction, and thymic atrophy. These results provide useful information for assessing the safety of compounds in toxicological studies, enabling direct treatment effects and secondary changes caused by decreased food intake to be distinguished.
Subject(s)
Eating , Toxicity Tests, Subacute , Alkaline Phosphatase/blood , Animals , Aspartate Aminotransferases/blood , Body Weight , Calcium/blood , Creatinine/blood , Dogs , Electrocardiography , Hematologic Tests , L-Lactate Dehydrogenase/blood , Liver/pathology , Male , Organ Size , Thymus Gland/pathologyABSTRACT
Glutamate-mediated excitotoxicity, mainly induced by N-methyl-d-aspartate (NMDA) receptors, is known to cause retinal ganglion cell death in retinal ischemia, glaucoma, and several other retinal diseases. We evaluated the effects of ß-estradiol (E2) against a single intravitreal injection of NMDA using a functional and morphological approach. Male rats were randomly divided into 3 treatment groups: (1) Control; (2) NMDA (intravitreal injection of 5 mM NMDA); and (3) NMDA + E2 (intravitreal injection of 5 mM NMDA and pretreatment with subcutaneous E2 implantation). Seven days after NMDA injection, full-field electroretinograms (ERGs) and quantitative morphological analyses using transverse sections of the retina were conducted. In the NMDA group, full-field ERGs showed reductions in the amplitudes of the negative-scotopic threshold response, rod response b-wave, oscillatory potentials, flicker response second b-wave and cone response b-wave. Morphological evaluations of transverse sections of the retina demonstrated a reduction in the thickness of the inner plexiform layer, increases in the thickness of the outer plexiform and outer nuclear layers, and a loss of cells in the ganglion cell layer. In the NMDA + E2 group, pretreatment with E2 prevented the aggravations in the amplitudes of the ERGs except for oscillatory potential 2 (OP2); however, no morphological differences between the NMDA and NMDA + E2 groups were seen. These findings indicate that E2 can protect retinal function against NMDA-induced neurotoxicity. In addition, these indications suggested that the effect of E2 may have therapeutic benefits in NMDA related diseases, such as retinal ischemia and glaucoma.
Subject(s)
Estradiol/pharmacology , Estrogens/pharmacology , Excitatory Amino Acid Agonists/toxicity , N-Methylaspartate/toxicity , Neuroprotective Agents/pharmacology , Retina/drug effects , Retinal Ganglion Cells/drug effects , Animals , Body Weight , Cell Count , Electroretinography/drug effects , Estradiol/blood , Estrogens/blood , Intravitreal Injections , Male , Rats , Rats, Sprague-Dawley , Retina/physiopathology , Retinal Ganglion Cells/physiologyABSTRACT
To assess whether ovarian histopathological examination in repeated-dose rodent toxicity study could reliably anticipate toxic effects on female reproductive function and to assess whether ovarian change could be detected in a 2-week repeated-dose toxicity study, tamoxifen was administrated orally to female rats at 0.005, 0.03, or 0.2 mg/kg/day for 2 and 4 weeks in the repeated-dose toxicity studies, and for 2 weeks prior to cohabitation, during cohabitation, and through Gestation Day 7 in a female fertility study. The relationship between ovarian histopathological findings and fertility results was investigated. Findings at 0.03 and 0.2 mg/kg/day included decreases in body weight gains associated with decreases in food consumption, in 2- and 4-week repeated-dose toxicity studies and fertility study. The ovarian histopathological findings included increases in large atretic follicles, increases in interstitium cells and absence of newly-formed corpus lutea at 0.2 mg/kg/day in the 2-week study and at 0.03 and 0.2 mg/kg/day in the 4-week study. The treatment induced estrogenic and antiestrogenic reactions in the uterus, while mucinous degeneration was detected in the vagina. Effects on female fertility consisted primarily of disturbance of estrus cycle and decreases in numbers of pregnant rats which were considered to be related to ovarian histopathological changes. Based on these findings, ovarian histopathological evaluation in the repeated-dose toxicity study could anticipate the effects of tamoxifen on female fertility via ovarian dysfunction at slightly toxic doses, and 2-week treatment of tamoxifen at appropriate dose could be sufficient to detect ovarian toxicity by microscopic examination.
Subject(s)
Fertility/drug effects , Ovary/drug effects , Selective Estrogen Receptor Modulators/toxicity , Tamoxifen/toxicity , Toxicity Tests/methods , Administration, Oral , Animals , Body Weight/drug effects , Drug Administration Schedule , Eating/drug effects , Estrous Cycle/drug effects , Estrous Cycle/physiology , Female , Fertility/physiology , Japan , Longevity/drug effects , Male , Organ Size/drug effects , Ovarian Follicle/drug effects , Ovarian Follicle/pathology , Ovary/metabolism , Ovary/pathology , Pregnancy , Public-Private Sector Partnerships , Rats , Rats, Sprague-Dawley , Rats, Wistar , Selective Estrogen Receptor Modulators/administration & dosage , Societies, Scientific , Tamoxifen/administration & dosage , Uterus/drug effects , Uterus/pathology , Vagina/drug effects , Vagina/pathologyABSTRACT
Previous studies revealed that atropine reduced male fertility in rats without any effects on mating performance, sperm production and motility, and testicular morphology. The present study was conducted to investigate whether the impairment of male fertility induced by atropine was related to the inhibition of sperm and semen transports from the vas deferens and seminal vesicle to the urethra during the process of emission. Male rats were treated with atropine at 125 mg/kg/day for 10-17 days prior to mating with untreated females. After confirmation of mating, male rats were euthanized and sperm number in the vas deferens and weights of the seminal vesicle and copulatory plug were determined as indicators of inhibition of sperm and semen transports, respectively. Reproductive status of mated females was determined on gestation days 15-17. A low pregnancy rate associated with a decreased number of implants was observed in females that mated with the atropine-treated males. The average number of sperm in the vas deferens was increased in the atropine-treated males. The average seminal vesicle weight in the atropine-treated males was greater than that of controls. The copulatory plug weights were decreased in the atropine-treated males. These results suggest that inhibitions of sperm and semen transports from the vas deferens and seminal vesicle to the urethra during the process of emission result in reduced male fertility in rats.
Subject(s)
Atropine/toxicity , Infertility, Male/chemically induced , Semen/drug effects , Sperm Transport/drug effects , Administration, Oral , Animals , Atropine/administration & dosage , Female , Fertility/drug effects , Infertility, Male/physiopathology , Male , Muscarinic Antagonists/administration & dosage , Muscarinic Antagonists/toxicity , Organ Size/drug effects , Pregnancy , Rats , Rats, Sprague-Dawley , Semen/cytology , Semen/physiology , Seminal Vesicles/drug effects , Seminal Vesicles/pathology , Sperm Count/methods , Spermatozoa/cytology , Time Factors , Vagina/drug effects , Vagina/physiology , Vas Deferens/drug effects , Vas Deferens/physiologyABSTRACT
Male rats were treated with a muscarinic receptor antagonist at 3, 10, and 100mg/kg/day for 4 weeks prior to mating with untreated females and their reproductive status was determined on gestation days (GD) 15-17. Treatment-related decreases in the pregnancy rate were observed at 100mg/kg/day without any effects on mating performance. Impairment of male fertility by this compound was also observed after treatment for 1 week, but there were no effects after a 1-week withdrawal period suggesting reversibility of the effect. There were no treatment-related effects on sperm production or motility, or testicular histopathology in any group. In order to determine whether the reduced fertility was a class effect of muscarinic receptor antagonists, atropine was examined. Males received atropine for 1 week at 62.5 and 125 mg/kg/day and were mated with untreated females. A low pregnancy rate associated with a decrease in the number of implantations was observed at 125 mg/kg/day. The effect on implantation was also observed at 62.5mg/kg/day. These findings suggest that the impairment of fertility in male rats induced by muscarinic receptor antagonists is a class effect, and has a relatively short onset of effect and is quickly reversible.